Ascendis Pharma A (ASND) EPS (Basic) Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 112.82% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 836.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 836.02% |
| Dec 31, 2025 | 7.90% |
| Sep 30, 2025 | 35.64% |
| Jun 30, 2025 | -136.96% |
| Mar 31, 2025 | -166.32% |
| Dec 31, 2024 | 57.97% |
| Sep 30, 2024 | 39.66% |
| Jun 30, 2024 | -13.40% |
| Mar 31, 2024 | 217.08% |
| Dec 31, 2023 | 55.24% |
| Sep 30, 2023 | -2.04% |
| Jun 30, 2023 | 252.36% |
| Mar 31, 2023 | 13.93% |
| Dec 31, 2022 | -70.37% |
| Sep 30, 2022 | -277.34% |
| Jun 30, 2022 | -151.80% |
| Mar 31, 2022 | -76.26% |
| Dec 31, 2021 | 86.55% |
| Sep 30, 2021 | 164.25% |
| Jun 30, 2021 | 38.33% |